Document:

ex10x1.htm

Exhibit 10.1

 

SETTLEMENT AGREEMENT

1.  Parties. The Parties to this Settlement Agreement (“Agreement”) are:

a.  Pure Bioscience, Inc. (“Pure”);

b.  Richmont Sciences, LLC, Richmont Holdings, Inc., Richmont Corporation and IV-7 Direct, LLC (collectively, “Richmont”); and

c.  The Coalition to Save Pure (the “Coalition”).

2.  Effective Date.  The Effective Date of this Agreement is July 9, 2012.

3.  Background.  Pure and Richmont Sciences, LLC entered into several contracts and/or agreements.  A dispute arose which resulted in litigation between the Parties which is currently pending in the Superior Court of the State of California, County of San Diego, Case No., 37-2011-00068594-CU-CO-EC, captioned Pure Bioscience, Inc. v. Richmont Sciences, LLC and related cross-claims (the “Litigation”).  In addition, Richmont Corporation has initiated a pending proxy solicitation effort in connection with the upcoming Pure annual stockholder meeting and election of Pure directors to its board (the “Proxy Solicitation”) which is now being pursued in the name of the Coalition.

4.  Purpose.  The purpose of this Agreement is to settle the Litigation and the Proxy Solicitation between the Parties.

5.  Dismissal of Litigation.  Within five days after the date of this Agreement, all Parties will dismiss all claims and cross-claims in the Litigation with prejudice, with each Party to bear its own attorneys’ fees, expenses and costs incurred in connection with the Litigation or any claims that were or could have been alleged in the Litigation.  No Party shall institute any future litigation in any court arising out of or related to the facts and circumstances upon which the Litigation and/or the Proxy Solicitation were based, or asserting any claims that were or could have been asserted in the Litigation and/or the Proxy Solicitation.

6.  Withdrawal of Proxy Solicitation.  Richmont and all their respective principals, agents, subsidiaries, affiliates and assigns, including but not limited to Richmont Corporation, John Rochon and John Rochon, Jr., shall take and shall cause the Coalition to take all reasonable and necessary efforts to withdraw and shall not resubmit, the Proxy Solicitation and any other nomination of persons for election to the Pure Board of Directors at the 2012 annual stockholder meeting or at any other annual or special meetings, and shall cease and desist the solicitation of proxies with respect to such election or any other matter that may be considered at such stockholder meeting.  Such efforts shall include but not be limited to withdrawing all correspondence informing Pure of any intent to nominate any directors for election at the annual meeting, and notifying the United States Securities Exchange Commission in writing of the termination of the proxy contest.  Richmont, including Richmont Corporation, shall support and vote for Pure’s proposed slate of directors at the next annual (2012) Pure stockholder meeting.

 

 

 

  

  

  

7.  Future Constitution of Board.  After the next annual meeting or Special Meeting of Stockholders of Pure at which directors are to be elected and at any and all adjournments, postponements, recesses, reschedulings or continuations thereof, Pure shall replace one member of the Pure Board of Directors with an independent director, and shall also add an additional independent director to Pure’s Board of Directors.  Pure shall make good faith efforts to do so within 12 months after the 2012 annual shareholder vote.

8.  Joint Press Release.  The Parties shall issue the attached Joint Press Release on July 10, 2012.

9.  Future Board Elections and Proxy Solicitations.  Richmont, including Richmont Corporation, shall not directly or indirectly initiate, join in or support any Pure stockholder Proxy Solicitation effort or any effort to remove or replace any Pure director for five years from the Effective Date of this Agreement.

10.  Releases.  Pure and Richmont do hereby mutually generally release each other from all claims, damages, liability or other relief of any sort, including all such claims which were alleged or could have been alleged in the Litigation and/or the Proxy Solicitation, except such claims or rights as are reserved or created under this Agreement.  Pure and Richmont do hereby fully and forever release and discharge each other, and their past, present, and future affiliates, predecessors, successors and assigns, and their respective past, present and future partners, officers, directors, agents, employees, and attorneys from any and all known, unknown, suspected or unsuspected, fixed, conditional or contingent claims or causes of action, debts, demands, contracts, covenants, liens, liabilities, losses, costs, expenses (including, without limitations, attorneys’ fees) or damages whatever kind or nature as they relate to the claims that are the subject of the incident described herein.  Pure and Richmont mutually acknowledge and agree that all prior contracts, agreements and other understanding between the parties prior to the date hereof have been terminated and that Richmont has no right, title or interest in or to any technology, intellectual property or products of Pure.

11.  Waiver of Civil Code Section 1542. All rights under Section 1542 of the Civil Code of the State of California are hereby expressly waived by all Parties with respect to any and all releases set forth herein.  It is understood that Section 1542 provides as follows:

A general release does not extend to claims which the creditor does not know or suspect to exist in his or her favor at the time of executing the release, which, if known by him or her, must have materially affected his or her settlement with the debtor.

 

12.  Persons Bound and Benefited.  This Agreement shall be binding upon and inure to the benefit of the Parties hereto, as well as all their successors, assigns, heirs, representatives, employees, principals, agents, affiliates, subsidiaries, officers, directors, members, partners, beneficiaries and investors.

 

13.  Non-Disparagement.  Neither Party, nor their respective affiliates or representatives shall directly or indirectly make false or misleading representations regarding, or otherwise disparage, the other Party, its affiliates or representatives, or its businesses, products, technologies, intellectual property or activities.

 

 

  

  

  

14.  No Admission.  This Agreement and it terms are in compromise of disputed claims and is not an admission of liability for all or any part of any such claims by any Party.

 

15.  Governing Law, Jurisdiction and Venue.  This Agreement was negotiated, executed and delivered, and is to be wholly performed, in San Diego, California, and the rights and obligations of the Parties shall be construed and enforced in accordance with, and governed by, the internal, substantive laws of the State of California.  The exclusive venue for any action to interpret or enforce this Agreement, or any action in which this Agreement may support a defense or counter-claim, shall be in the Superior Court for the State of California, San Diego County.

 

16.  Enforcement Pursuant to California Code of Civil Procedure Section 664.6.  The Superior Court in which the Litigation was filed shall retain jurisdiction pursuant to California Code of Civil Procedure Section 664.6 to enforce this Agreement until performance in full, including but not limited to by entry of the Stipulated Judgment.

 

17.  Alternative Jurisdiction to Enforce.  If the Superior Court declines to enforce this Agreement pursuant to the procedures under Code of Civil Procedure Section 664.6, then any alternative action to enforce, for breach of, or arising out of this Agreement shall be commenced in the Superior Court for the State of California, County of San Diego, and the Parties each agree and consent to jurisdiction over them in that court for any such proceeding.

 

18.  Waiver of Jury Trial.  Each Party waives, to the fullest extent permitted by applicable law, any right it may have to a trial by jury in respect of any suit, action or proceeding directly or indirectly arising out of, under or in connection with any of this Agreement.

 

19.  Integration.  This Agreement constitutes the entire agreement between the Parties with respect to the settlement, payment, dismissal, releases, and all other matters and terms referenced herein, and supersedes any and all prior or contemporaneous representations, warranties or other statements of any Party, their attorneys or agents in connection with the negotiation or execution of this Agreement.  Without limiting the foregoing, the Parties agree that in any dispute arising out of this Agreement, no evidence relating to the negotiation or drafting of this Agreement, or any prior drafts of this Agreement, shall be admissible as evidence for any purpose, including but not limited to interpreting this Agreement or the intention of the Parties.

 

20.  Amendment.  This Agreement may only be amended or modified in writing executed by the Parties.

21.  Agreement Understood.  The Parties certify they have read all of this Agreement, consulted with and received legal advice from their respective attorneys concerning this Agreement, and understand and agree to the terms of this Agreement.

22.  Involvement of Counsel.  The Parties acknowledge they have been represented by legal counsel of their choosing in the negotiation and drafting of the terms of this Agreement, each Party enters into this Agreement of its own volition, freely and without coercion, based on its own judgment and advice of its own counsel, and not in reliance on any representations or promises of the other Party except as expressly set forth herein.

 

 

  

  

  

23.  Joint Preparation.  This Agreement has been jointly negotiated and drafted, and is not to be construed against any Party on the basis that it was the drafter.

24.  Authority.  Each Party executing this Agreement warrants he, she or it is the sole owner of the rights and obligations referred to and released herein, has not assigned or otherwise transferred any interest in any such rights or obligations, and is authorized to execute this Agreement personally or on behalf of any entity for whom he or she is acting.

25.  Counterparts and Facsimile Signatures.  This Agreement may be executed in counterparts, and such counterparts, taken together, shall constitute a single agreement.  Electronically transmitted signatures affixed to a counterpart shall have the force and effect of an original signature.

26.  Cooperation and Execution of Additional Documentation.  The Parties shall cooperate and execute additional documentation which may be required to implement, memorialize or carry out the provisions and intent of this Agreement.

Approved:

 

	 	 
Morrison & Foerster LLP

	 
	 	 	 	 
	
Dated: July 10, 2012 

	
By: 

	/s/ Mark R. Wicker	 
	 	 	Mark R. Wicker	 
	 	 	 
Wingert Grebing Brubaker & Juskie LLP

	 
	 	 	Attorneys for Pure Biosciences Inc.	 

 

 

	 	 
 

	 
	 	 	 	 
	
Dated: July 10, 2012 

	
By: 

	/s/ Andrew A. Servais	 
	 	 	 
Andrew A. Servais

	 
	 	 	 
 
 
Attorneys for Richmont Sciences LLC,

Richmont Holdings, Inc. and

IV-7 Direct, LLC

	 
	 	 	 	 

 

 

 

  

  

  

Agreed:                                                            

 

	 	 
 
Pure Bioscience, Inc.

	 
	 	 	 	 
	
Dated: July 10, 2012 

	
By: 

	/s/ Michael L. Krall	 
	 	 	 
Michael L. Krall

	 
	 	 	 	 

 

	 	 
 
 
Richmont Sciences, LLC

	 
	 	 	 	 
	
Dated: July 10, 2012 

	
By: 

	/s/ John Rochon, Jr.	 
	 	 	 
John Rochon, Jr.

	 
	 	 	 	 

 

	 	 
 
 
Richmont Holdings, LLC

	 
	 	 	 	 
	
Dated: July 10, 2012 

	
By: 

	/s/ John Rochon, Jr.	 
	 	 	 
John Rochon, Jr.

	 
	 	 	 	 

 

	 	 
 
 
Richmont Corporation

	 
	 	 	 	 
	
Dated: July 10, 2012 

	
By: 

	/s/ John Rochon, Jr.	 
	 	 	 
John Rochon, Jr.

	 
	 	 	 	 

 

	 	 
 
 
IV-7 Direct, LLC

	 
	 	 	 	 
	
Dated: July 10, 2012 

	
By: 

	/s/ Heidi Hafer	 
	 	 	 
Heidi Hafer

	 
	 	 	 	 

 

	 	 
 
 
The Coalition to Save Pure

	 
	 	 	 	 
	
Dated: July 10, 2012 

	
By: 

	/s/ John Rochon, Jr.	 
	 	 	 
John Rochon, Jr.ex10_1.htm

EXHIBIT 10.1

 

July 11, 2012

D. Andrew Myers

464 Coventry Place

Danville, CA  94506

	
Re: 

	
Confidential Separation and Release Agreement

Dear Andy:

 

This letter sets forth the substance of the separation and release agreement (the “Agreement”) which Scientific Learning Corporation (“Scientific Learning”) is offering to you to aid in your employment transition.  You will only receive the benefits described in Paragraphs 3 and 4 below if you sign and return this Agreement to Scientific Learning within the time set forth in Paragraph 12 below.

 

1.             Separation.  You and Scientific Learning have mutually agreed that your employment will end on August 1, 2012 (the “Separation Date”).

 

2.             Accrued Salary and Paid Time Off.  On the Separation Date, Scientific Learning will pay you all accrued salary, and all accrued and unused Paid Time Off earned through the Separation Date, subject to standard payroll deductions and withholdings.  You are entitled to these payments regardless of whether or not you sign this Agreement.

 

3.             Severance Payments.  Scientific Learning will pay you, as severance, twelve (12) months of your base wages in effect as of the Separation Date subject to standard payroll deductions and withholdings (“Severance Payments”).  The Severance Payments will be made on the Company’s ordinary payroll dates, commencing with the first payroll date after the Effective Date of this Agreement as defined in Paragraph 12, below. Contingent upon your fulfillment of the terms of the Consulting Agreement described in Section 5 below, if you have not accepted a new full time position at the end of this 12 month period your base wages severance payments will continue until either you have accepted a new position, or for three additional months, whichever is first. For the avoidance of doubt, the original twelve months of base wages is not subject to any contingency relating to the Consulting Agreement nor is it subject to reduction if you accept a new position.

 

4.             Benefits and Insurance.  All Scientific Learning benefits and insurance cease as of the Separation Date except for health care benefits (medical, dental and vision coverage) which are in effect until the last day of the month in which your employment ends.  After this date and to the extent permitted by the federal and state COBRA law and the insurance policies and rules applicable to Scientific Learning, you will be eligible to continue your health care benefits and, later, to convert to an individual policy.  You will be provided with a COBRA notice setting forth your rights and responsibilities with regard to COBRA coverage within two weeks of the termination of your coverage.  This notice will be sent to you from COBRA Management Services on behalf of Scientific Learning.  If you choose to sign this Agreement, and if you actively elect COBRA coverage through COBRA Management Services, Scientific Learning will pay the COBRA premiums (for medical, dental and vision) for you and your eligible dependents, for the months of September 2012 through February 2014 or until you have medical benefits available to you through another employer.

 

	 	
Confidential Separation and Release Agreement

	 
	 	
D. Andrew Myers

	 
	 	
July 11, 2012

	

Initial: /s/ am

 

  

  

  

 

5.             Consulting Agreement.  You and the Company have agreed to enter into a Consulting Agreement for the period of August 2, 2012 through December 31, 2012, in the form attached hereto as Exhibit A (the “Consulting Agreement”). Your service under this Consulting Agreement will constitute Continued Service for purposes of all outstanding and unexercised employee stock options and restricted stock units from the Company that you presently hold.

 

6.             No Other Compensation or Benefits.  Other than the Severance Pay, Company paid COBRA premiums, and Consulting Agreement specified in Paragraphs 3, 4 and 5, you will receive no other wages, insurances, bonuses, vacation pay, benefits, or other monies or benefits from Scientific Learning at any time, and you agree that you are entitled to no other wages, benefits, insurances, bonuses, vacation pay or other monies of any nature from Scientific Learning.  If you do not enter into the Consulting Agreement, then you will have 90 days from your Separation Date to exercise any vested options; if you do enter into the Consulting Agreement, then you will have 90 days from the termination of the Consulting Agreement to exercise any vested options.  This agreement supersedes any and all benefits to which you were entitled under your employment offer letter agreements with the Company dated November 28, 2007 and December 15, 2008, and you waive any rights you have thereunder.

 

7.             Return of Scientific Learning Property.  If you and the Company do not enter into the Consulting Agreement, you agree to return to Scientific Learning all Scientific Learning documents (and all copies thereof) and other Scientific Learning property which you have had in your possession at any time, including, but not limited to, Scientific Learning files, notes, records, business plans and forecasts, financial information, specifications, computer-recorded information, tangible property (including, but not limited to, computers, pagers or cell phones), credit cards, entry cards, identification badges and keys, and any materials of any kind which contain or embody any proprietary or confidential information of Scientific Learning (and all reproductions thereof) within fifteen (15) days after the Separation Date. If you and the Company do enter into the Consulting Agreement, then the obligation under the first sentence of this Section 7 shall become effective within fifteen (15) days after the end of the Consulting Agreement. The exception to this is that you may keep the laptop and cell phone issued to you by the Company.

 

8.             Proprietary Information Obligations.  After your employment and, if you and the Company enter into it, the term under the Consulting Agreement, you will refrain from any use or disclosure of Scientific Learning’s proprietary or confidential information or materials. In addition, you acknowledge your continuing obligations under your Proprietary Information and Inventions Agreement, including, without limitation, your obligation not to use or disclose any confidential or proprietary information of Scientific Learning without prior written authorization from a duly authorized representative of Scientific Learning.  A copy of your Proprietary Information and Inventions Agreement is attached hereto as Exhibit B.

 

	 	
Confidential Separation and Release Agreement

	 
	 	
D. Andrew Myers

	 
	 	
July 11, 2012

	
Initial: /s/ am

 

  

  

  

 

9.             Confidentiality.  The provisions of this Agreement shall be held in strictest confidence by you and shall not be publicized or disclosed in any manner whatsoever; provided, however, that you may disclose this Agreement in confidence to your immediate family, attorney, accountant, tax preparer, and financial advisor and you may also disclose this Agreement insofar as such disclosure may be necessary to enforce its terms or as otherwise required by law.

 

10.           Non-Disparagement.  You agree not to disparage Scientific Learning or Scientific Learning’s directors, employees, and members, in any manner likely to be harmful to them or their business, business reputations or personal reputations, including by posting statements or images that are likely to be harmful to their business reputations or personal reputations on Facebook, Twitter, or any other social media site.   Scientific Learning agrees not to, and agrees to instruct its employees not to, disparage you in any manner likely to be harmful to you or your business, business reputation or personal reputation, including by posting statements or images that are likely to be harmful to your business reputation or personal reputation on Facebook, Twitter, or any other social media site.

 

11.           Release.  To the fullest extent permitted by law, you hereby generally and completely release Scientific Learning, and its respective directors, officers, employees, shareholders, partners, agents, attorneys, predecessors, successors, parent and subsidiary entities, insurers, ERISA plans, current and former trustees and administrators of ERISA plans, affiliates, and assigns (“Released Parties”) from any and all claims, liabilities and obligations, both known and unknown, that arise out of or are in any way related to events, acts, conduct, or omissions occurring prior to your signing this Agreement.  This general release includes, but is not limited to: (1) all claims arising out of or in any way related to your employment with Scientific Learning or the termination of that employment; (2) all disputed claims related to your compensation or benefits from Scientific Learning or the Released Parties, including salary, bonuses, commissions, vacation pay, expense reimbursements, severance pay, fringe benefits, stock, stock options, or any other ownership interests in Scientific Learning or the Released Parties; (3) all claims for breach of contract, wrongful termination and breach of the implied covenant of good faith and fair dealing; (4) all tort claims, including claims for fraud, defamation, emotional distress, and discharge in violation of public policy; and (5) all federal, state, and local statutory claims, including claims for discrimination, harassment, retaliation, attorneys’ fees, or other claims arising under the federal Civil Rights Act of 1964 and 1991 (as amended) and the California Fair Employment and Housing Act (“FEHA”), as amended (each of which may include claims for age, race, color, ancestry, national origin, disability, medical condition, marital status, sexual orientation, gender, gender identity, gender expression, religious creed, pregnancy, sex discrimination and harassment); the federal Age Discrimination in Employment Act of 1967 (as amended) (“ADEA”); the Employee Retirement Income and Securities Act (“ERISA”); the Family and Medical Leave Act ("FMLA"); the California Family Rights Act ("CFRA"); the federal Americans with Disabilities Act of 1990 ("ADA"); the federal Equal Pay Act, of 1963, as amended; California Business and Professions Code 17200; any and all protections pursuant to California’s Labor Code, laws, statutes or orders or the Fair Labor Standards Act (“FLSA”), any wage and hour law (including any claim for waiting-time penalties); privacy rights; whistleblower protections; and constitutional protections.  This release does not include claims that cannot be released as a matter of law, including, but not limited to, any claims for unemployment insurance with the State of California, any insured claims against Scientific Learning’s workers’ compensation insurance carrier, and your right to file a charge with or participate in a charge by the Equal Employment Opportunity Commission, or any other local, state, or federal administrative body or government agency that is authorized to enforce or administer laws related to employment, against Scientific Learning (with the understanding that any such filing or participation does not give you the right to recover any monetary damages against Scientific Learning; your release of claims herein bars you from recovering such monetary relief from Scientific Learning).

 

	 	
Confidential Separation and Release Agreement

	 
	 	
D. Andrew Myers

	 
	 	
July 11, 2012

	

Initial: /s/ am

 

  

  

  

 

12.           ADEA WAIVER. You hereby acknowledge that you are knowingly and voluntarily waiving and releasing any rights you may have under the ADEA.  You also acknowledge that the consideration given for the foregoing waiver is in addition to anything of value to which you were already entitled.  You have been advised by this writing, as required by the ADEA that: (a) your waiver and release do not apply to any claims that may arise after your signing of this Agreement; (b) you should consult with an attorney prior to executing this release; (c) you have forty-five (45) days within which to consider this release (although you may choose to voluntarily execute this release earlier); (d) you have seven (7) days following your execution of this Agreement to revoke the Agreement; and (e) this Agreement will not be effective until the eighth day after this Agreement has been signed by you (“Effective Date”).

 

13.           Acknowledgement of Release.  YOU UNDERSTAND THAT THIS AGREEMENT INCLUDES A RELEASE OF ALL KNOWN AND UNKNOWN CLAIMS.  You acknowledge that you have read and understand Section 1542 of the California Civil Code which reads as follows:  “A general release does not extend to claims which the creditor does not know or suspect to exist in his or her favor at the time of executing the release, which if known by him or her must have materially affected his or her settlement with the debtor.”  You hereby expressly waive and relinquish all rights and benefits under that section and any law of any jurisdiction of similar effect with respect to your release of any unknown or unsuspected claims you may have against Scientific Learning, its affiliates, and the entities and persons released herein.

 

14.           Your Assistance in Dismissing Administrative Claims.  You acknowledge and warrant that there are no claims or actions currently filed or pending relating to the subject matter of the Agreement.  You hereby request all administrative agencies having jurisdiction over employment and labor law matters and courts to honor your release of claims under this Agreement.  Should Scientific Learning ever request you to execute any administrative dismissal forms, you shall immediately execute the form and return it to Scientific Learning.  Should you file any claim or action relating to the subject matter of this Agreement, such filing shall be considered an intentional breach of the Agreement and you will be subject to all damages available under law and equity, including without limitation, the amount of severance paid hereunder.

 

	 	
Confidential Separation and Release Agreement

	 
	 	
D. Andrew Myers

	 
	 	
July 11, 2012

	

Initial: /s/ am

 

  

  

  

 

15.           Certification of No Work-Related Injuries.  You agree, warrant and covenant that you have not experienced or suffered any work-related occupational injuries or diseases (physical, mental or otherwise) arising out of or in the course of your employment with Scientific Learning.  You further certify that you have not failed to report any work-related occupational injuries or diseases arising out of or in the course of your employment with Scientific Learning.

 

16.           Non-Admission of Liability.  This Agreement shall not be construed to be an admission of any liability to you or to any other person.

 

17.           Voluntary Agreement and Representation of Understanding.  You represent that you have thoroughly read and considered all aspects of this agreement that you understand all its provisions and that you are voluntarily entering into said agreement.  You also represent that you have been advised of your right to consult with an attorney before signing this agreement and that you have consulted with an attorney or voluntarily chosen not to do so.

 

18.           Miscellaneous.  This Agreement constitutes the complete, final and exclusive embodiment of the entire agreement between you and Scientific Learning with regard to this subject matter.  It is entered into without reliance on any promise or representation, written or oral, other than those expressly contained herein, and it supersedes any other such promises, warranties or representations.  This Agreement may not be modified or amended except in a writing signed by both you and a duly authorized officer of Scientific Learning.  This Agreement shall bind the heirs, personal representatives, successors and assigns of both you and Scientific Learning, and inure to the benefit of both you and Scientific Learning, their heirs, successors and assigns. If any provision of this Agreement is determined to be invalid or unenforceable, in whole or in part, this determination will not affect any other provision of this Agreement and the provision in question shall be modified by the court so as to be rendered enforceable.  This Agreement shall be deemed to have been entered into and shall be construed and enforced in accordance with the laws of the State of California as applied to contracts made and to be performed entirely within California.

 

This Agreement may be executed in counterparts which shall be deemed to be part of one original, and facsimile signatures and signatures transmitted by PDF shall be equivalent to original signatures.

 

If this Agreement is acceptable to you, please sign and return to me.

 

Thank you for your contributions to Scientific Learning.  We wish you the best in your future endeavors.

Sincerely,

 

	
/s/ Robert C. Bowen

	 
	
Robert C. Bowen

	
Chairman of the Board of Directors

 

	 	
Confidential Separation and Release Agreement

	 
	 	
D. Andrew Myers

	 
	 	
July 11, 2012

	

Initial: /s/ am

 

  

  

  

 

Agreed And Accepted:

 

By signing this letter, I acknowledge that I have had the opportunity to review this Agreement carefully with an attorney of my choice or have voluntarily chosen not to do so, that I understand the terms of the Agreement, and that I voluntarily agree to them.

 

	/s/ Andy Myers	 	July 12, 2012	 
	D. Andrew Myers	 	Date	 

 

Exhibit A – Consulting Agreement

 

Exhibit B - Proprietary Information and Inventions Agreement

 

	 	
Confidential Separation and Release Agreement

	 
	 	
D. Andrew Myers

	 
	 	
July 11, 2012

	

Initial: /s/ am

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00205-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00205-of-00352.parquet"}]]